Email address
[email protected]Contact number
+852 2846 1888Chambers Review
Baker McKenzie offers unrivalled geographical coverage with respected life sciences teams throughout Asia providing a full-service offering. The team is highly experienced across the full range of life sciences topics, offering particular strength in IP and also providing expert advice on competition, compliance and corporate transactions. The group maintains strong relationships with a range of governmental bodies, making for a comprehensive regulatory service. Baker McKenzie serves leading global healthcare, pharmaceutical and medical device companies on major cross-border deals. The inclusion of medical experts and healthcare practitioners in its teams ensures deep industry knowledge.
Isabella Liu and Clement Ngai are key contacts for the firm's China life sciences practice and are based in Hong Kong and Shanghai respectively. Tokyo-based Hideo Norikoshi and Kei Matsumoto are main contacts in the Japan IP team, and Elisabeth White is the main contact based in Australia.
Work Highlights
- Baker McKenzie advised Hefei Tianhui Biotechnology on its joint venture collaboration with Oramed Pharmaceuticals and Oramed.
Strengths
Provided by Chambers
"The team could always respond on very complex matters with a very professional yet commercially sensible solution."
"Baker McKenzie offers strong understanding of the regulations and a very commercial approach rather than simply a black-and-white view."
"The team could always respond on very complex matters with a very professional yet commercially sensible solution."
"Baker McKenzie offers strong understanding of the regulations and a very commercial approach rather than simply a black-and-white view."